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Abstract 
The Kootenay Boundary (KB) region has a high incidence of pertussis compared to 
other areas in the province of British Columbia (BC), and NPs can be effective agents of 
change to reduce this incidence. The focus of this project is to critically examine and provide 
a guide to NPs working in primary care on the following question: What is the role ofthe NP 
in primary health care in increasing the immunization rates of adult dTap and subsequently 
decreasing pertussis morbidity in the KB population? 
In response to the research question it was found that NPs must have a higher 
degree of suspicion for pertussis in adults when presented with a common cough because 
evidence indicates that pertussis in adults is poorly understood and under-diagnosed by 
primary health care providers (Kretsinger et al., 2006; Public Health Agency of Canada, 
2006a; De Serres, 2003). NPs also need to educate patients about the Canadian and 
American guidelines that all adults aged 19-64 years of age should receive dTap in 
replacement of the Td vaccine who have not received one dose of acellular pertussis 
despite the cost to the individual (De Serres, 2003, Kretsinger et al., 2006). In particular, NPs 
should identify and focus on target populations who are at greater risk of acquisition and 
transmission of pertussis including adults who are in contact with children. To increase 
immunization rates in primary care NPs need to enhance access to vaccination services 
(expanded access in health-care settings or reduced client out-of-pocket costs) with either a 
provider- or system-based intervention (standing orders, provider reminder systems, or 
provider assessment and feedback) or an intervention to increase client or community 
demand for vaccination (client reminders or client education) (Briss et al., 2000; Task Force 
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on Community Preventive Services, 2000). Evidence indicates that reducing out-of-pocket 
costs independent of other interventions improves vaccination coverage in adults (Briss et 
al., 2000; Task Force on Community Preventive Services, 2000; Public Health Agency of 
Canada, 200Gb). Therefore NPs are encouraged to lobby their local political representatives 
to change BCCDC policy to extend financial support to include the pertussis vaccination for 
adults. 
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Background and Need 
Introduction 
Bordetella pertussis, also known as "whooping cough," is a gram-negative bacterium 
that causes an acute, communicable infection of the respiratory tract (Byrd & Ohl, 2009). It 
causes a prolonged illness in children and adults, resulting in frequent explosive coughing 
spells that interfere with daily function . Pertussis means "violent cough." Infected persons 
are extremely contagious via aerosol droplets transmitted during coughing (Byrd & Ohl, 
2009). 
The Kootenay Boundary (KB) region in British Columbia (BC) reported 108 cases of 
pertussis in 2006 (see Appendix A), an equivalent rate of 134.4 per 100,000 people, which is 
more than seven times the rate of any other health service delivery area in British Columbia. 
The average British Columbian and Canadian pertussis rates in 2006 were 4.8 and 7.1 per 
100,000 people respectively (BC Centre for Disease Control, 2007). 
Despite the recommendations from the National Advisory Committee on 
Immunizations (NACI) to best protect adults with a single dose of pertussis vaccine, 
immunization coverage for this disease in Canadian adults is the lowest of all vaccines, at 
four percent (Public Health Agency of Canada, 2006a). While pertussis has generally been 
considered an infection of children, associated with considerable morbidity and mortality, it 
is increasingly being recognized in adults (Skowronshi et al., 2004). In fact the adolescent 
(;:::15 years) and adult proportion of pertussis cases in Canada increased from 7.3% in 1988 
to 10.3%, 17%, and 23% in 1992, 1998, and 2000 respectively (De Serres, 2003). Symptoms 
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of pertussis in adults, most often milder than in children, involve a prolonged indistinct 
cough lasting two to six weeks. This lack of distinctiveness leads to underdiagnosis, and 
consequently the adult population serves as a major reservoir of infection and an important 
source of transmission to more vulnerable age groups. Infants remain at highest risk of 
severe complications including failure to thrive, apnea, pneumonia, respiratory failure, 
seizures, and death (Byrd & Ohl, 2009). As well, adults with pertussis can have 
complications, including pneumonia (5% of adult cases), rib fractures (4% of adult cases) 
and "cough syncope" (6% of adult cases) (Kretsinger et al., 2006). 
As a NP student learning in primary care in Castlegar, Nelson, and Trail, BC, along 
with work experience in the emergency department, the author has had the opportunity to 
identify seemingly high rates of pertussis by either clinical diagnosis or thorough past 
medical histories in patients of all ages in the KB region. In addition to learning about 
pertussis through a process of evidence based practice, the author also read supporting 
literature to immunize adults against pertussis. It became evident through discussions with 
KB primary care providers (PCPs) that the medical community lacks knowledge and 
subsequent counseling in support for adult pertussis vaccination, which is contradictory to 
practice guidelines. 
Nurse Practitioners are instrumental in, and have a professional obligation to provide 
health promotion/prevention strategies to improve population health, including pertussis 
adult immunization. The process of understanding the broader picture and challenging the 
structural and established underpinnings that impinge on health and access to resources are 
central concerns to NPs (Browne & Tarlier, 2008). Immunizations are a common question 
that occurs in the primary care clinic, including how to best protect oneself from 
communicable diseases, including pertussis? 
This project and the following review of literature stemmed from the author's 
observations of the evidence that supports pertussis adult immunizations and its conflict 
with common primary care clinical practice in KB region . Furthermore, these are aspects of 
practice that influence NPs in primary care. 
History of the pertussis vaccine 
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Whole cell fluid pertussis vaccine was introduced in Canada on a widespread basis in 
the 1940's (whole-cell vaccine era) in response to the high rate of pertussis, which was 
estimated to be 160 cases per 100,000 at the time. This resulted in a marked decline in 
incidence of the disease to less than 20 cases per 100,000 by the 1980's. This vaccine was 
gradually replaced by the combined, adsorbed diphtheria-tetanus-pertussis whole cell 
vaccine after 1980 (pre dTap era) and then by the acellular vaccine (dTap era) in 1997-1998 
(National Advisory Committee on Immunization, 2003). 
Between 1990 and 2000, there was a resurgence of pertussis largely attributable to 
the low efficacy range of 20% to 60% of the combined adsorbed diphtheria-tetanus-
pertussis whole cell vaccine used in Canada between 1980 and 1997 (pre dTap era) 
(National Advisory Committee on Immunization, 2003). These whole-cell vaccines were 
administered only to children up to six years of age. Unfortunately, due to waning 
immunity, many vaccinated children became susceptible to pertussis in adolescence or 
adulthood (Public Health Agency of Canada, 2005). Adults at highest risk and subsequent 
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lowest immunity to pertussis are those who were vaccinated with the whole-cell vaccine 
used in the 1980s and 1990s. 
In 1997, dTap vaccine, which contains "acellular pertussis antigens combined with 
tetanus toxoid and reduced diphtheria toxoid" (Pichichero et al., p. 1085, 2006), replaced 
the earlier adsorbed whole-cell version. The dTap vaccine exhibits fewer side-effects and 
higher efficacy, and consequently is considered safe to use on adolescents and adults 
(Skowronshi et al., 2004). The National Advisory Committee on Immunizations (NACI) 
recommends that dTap vaccine is given at 2,4,6, and 18 months, followed by a preschool 
vaccine at 4 to 6 years of age and as a single dose booster for adolescents and adults (Public 
Health Agency of Canada, 2005). 
The clinical efficacy of dTap was measured at 85% for infants who received three 
doses of the vaccine (National Advisory Committee on Immunization, 2003). Single dose 
boosters for adolescents and adults have been shown to increase antibody levels in excess 
of those of vaccinated infants (Skowronshi et al., 2004). Immunity to pertussis by dTap is 
not life long, and the duration of protection given by that booster dose is not known. Only 
one dose is currently recommended for adolescents and adults (National Advisory 
Committee on Immunization, 2003). 
Rate of Pertussis in the Kootenay Boundary Region 
Pertussis is cyclical and peaks every three to five years. British Columbia Centre for 
Disease Control (BCCDC, 2007) suggests that these peaks occurred in 2000, 2003 and 2006. 
The corresponding rate of pertussis in the KB region was 119.6, 55.4 and 134.4 per 100,000 
populations, respectively. This rate reflects people of all ages that are only diagnosed 
utilizing culture or PCR methods (J. Fraser, personal communication, September 3, 2009), 
which will be discussed further in this project. The breakdown of rates per age group was 
not reported. Surveillance is further complicated by "problems relating to under-diagnosis 
of pertussis in adolescents and adults, assessment of immunization coverage in adults, the 
lack of a national network of immunization registries to collect data on immunization and 
disease status, and the impact of improvements in diagnostics or diagnosis on reported 
cases" (Public Health Agency of Canada, 2005, p. 2}. This was reflected in a personal recent 
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NP clinical experience in primary care in Nelson, BC, where a ten year old girl was diagnosed 
with pertussis via the PCR method. Antibiotic treatment was provided to the PCR diagnosed 
patient, as well as her younger four year-old sister and her parents, who were clinically 
diagnosed. The whole family had a cough and symptoms that were indistinguishable from 
an upper respiratory infection. The parents were immunized with whole cell pertussis and 
their children had not received any immunizations. Likely, all members of the family had 
pertussis, however only one case was reported to the BCCDC since it was the only case 
confirmed by PCR. J. Fraser (personal communication, September 3, 2009} from the IHA 
Center of Disease Department commented that this type of scenario is not uncommon, 
whereby a single case is reported to the BCCDC, but many more cases are treated if they are 
symptomatic and have been exposed to a person with a laboratory confirmed diagnosis of 
pertussis. 
In Canada, pertussis is a national notifiable disease, meaning that health care 
practitioners are required to report all cases to public health authorities. This is an attempt 
to monitor the disease, and provide early warning of possible outbreaks. The difficulty with 
pertussis surveillance is it lacks standardized reporting practices. Surveillance is further 
challenged by under-diagnosis of pertussis in adolescents and adults. In addition, 
surveillance does not take into account the impact of improvements in diagnostics (Public 
Health Agency of Canada, 2005). 
Research question 
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To better understand current knowledge and evidence on adult pertussis immunizations, 
a literature review was conducted. To guide this review, the project was formulated around 
the following clinically significant research question: 
What is the role ofthe NP in primary health care in increasing the immunization rates of 
adult dTap and subsequently decreasing pertussis morbidity in the KB population? 
This proposed increase in adult immunization rates in the KB area would correspond with a 
subsequent decrease in the reservoir of infection in adults. This in turn would reduce 
incidence of pertussis in all ages most importantly in vulnerable populations such as infants, 
the elderly and immunocompromised persons. Other potential benefits would include 
decreased health care costs in terms of hospital-days, less time lost in employment sick days 
and a general decrease in the suffering of disease to the people in the KB region (Bloom, 
Canning & Weston, 2005). 
The NP Role and Significance to the Project 
Health promotion implies the enabling process of people to gain control over, and 
ultimately improve their health (World Health Organization, 1998}. 'Population health' is a 
term describing a holistic approach to health care that addresses multiple factors that 
determine health, which in turn, affects the health of the entire population (Public Health 
Agency of Canada, 2001). Health promotion and population health, also known as 
population health promotion, are interdependent and are at the core of NP practice. 
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The College of Registered Nurses of British Columbia (2006) identifies health 
promotion and illness prevention as comprising one ofthe four pillars of NP practice. More 
specifically, the Prior Learning Assessment and Recognition Framework for Assessing Nurse 
Practitioners (2006) states that NPs are not only to "identify and respond to trends or 
patterns that have health implications for individuals, families, groups or communities", but 
also "contribute to health promotion/prevention strategies" as well as "advocate for 
individuals, families, groups and communities and their health care needs" (CRNBC, p.8, 
2006). Preventing pertussis through adult immunizations is relevant to NP practice and 
encourages population health promotion. 
The literature indicates that only 4% of the Canadian adult population is vaccinated 
against pertussis. It is not uncommon for many KB people to choose not to vaccinate their 
children, which inevitably results in low childhood immunization rates (Dr. B. Woodward, 
personal communication, July 16, 2009). This issue lends to the assumption that the cause 
of high rates of pertussis in the KB is directly related people's choice to avoid immunizations 
because they are 'against them.' It is indisputable that low rates of childhood immunization 
lead to increased rates of pertussis; however, upon researching this topic further the 
following health promotion/prevention strategies became evident. 
First, there are other ways to protect communities from pertussis, including the 
National Advisory Committee on Immunizations (2003) recommendation to immunize 
adults with acellular pertussis vaccine. Secondly, there is a lack of awareness among Primary 
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Care Practitioners (PCPs) of this recommendation, as well as pertussis' high incidence, 
severity and complications in adults. This leads to PCPs not recommending the adult 
pertussis vaccine to their patients, as well as underdiagnosis (Public Health Agency of 
Canada, 2006a). Ironically, all preceptors (including the author) fully support and encourage 
immunizations to their patients, but are not immunized with acellular pertussis. This is 
particularly concerning given that health care providers have 1.7 times greater risk of 
pertussis morbidity (De Serres et al., 2000). Therefore encouraging policy change to fund 
adult pertussis vaccinations is an alternative way to decrease the incidence of pertussis 
while respecting people's health choices within the KB region. 
The second chapter reviews the literature concerning the role of NPs in effectively 
creating and implementing change to increase adult pertussis vaccination administration. 
More specifically, this chapter reviews evidence on adult dTap recommendations, factors 
affecting low pertussis adult vaccination rates, strategies to improve vaccine uptake in 
adults and an analysis of cost effectiveness and cost benefit of adult dTap vaccination, 
which includes direct medical and non-medical costs, such as laboratory tests, ambulatory 
visits, hospitalizations, transportations, childcare and over-the-counter medications, as well 
as lost productivity costs. In response to a critical analysis of the literature, conclusions 
derived from the studies and their implications for practice will also be discussed in brief in 
this chapter. 
The third and final chapter will focus further on the implications drawn from the 
literature review and suggest subsequent recommendations for Nurse Practitioners. This 
project addresses immunizations to the adult population, which is defined as women and 





Sources and Search Process 
A thorough literature review was conducted utilizing the data bases CINAHL, EBSCO, 
MEDLINE, Cochrane, SAGE, PYCHINFO, Health Technology Assessment, and NHS Economic 
Evaluations. In addition, the Public Health Agency of Canada, the BCCDC and the American 
Centre for Disease Control and Prevention websites were accessed to gain additional 
information to respond to the research question. Keywords used in the search included 
adult, "Nurse Practitioner", implementation, pertussis, whooping cough, cost benefit 
analysis, costs and cost analysis, diphtheria tetanus acellular pertussis vaccine, and 
immunization. Studies published after the year 1999 were included. Articles that did not 
directly relate to the research question or were written in languages other than English 
were excluded. Utilizing these resources and restrictions, twenty-two sources, which 
included one systematic review (that analyzed 183 studies), four meta-analyses, nine clinical 
practice guidelines, one Canadian National survey, one Canadian National conference 
report, and one provincial (BC) summary of reportable diseases were found, examined and 
analyzed. 
Four themes related to NP implementation to increase pertussis immunizations 
emerged from the literature review, including the following: 
1. Adult dTap recommendations 
2. Factors affecting low pertussis adult vaccination rates 
3. Strategies to improve vaccine uptake in adults 
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4. Cost-benefit and cost-effectiveness analysis of adult dTap 
vaccination 
Adult dTap Recommendations 
Use of the dTap vaccine for adults who did not receive the acellular pertussis in their 
primary vaccine series is not included in the British Columbia Centre for Disease Control 
(BCCDC) guidelines {2009). The exclusion of dTap is not supported by the Canadian NACI, or 
the American Advisory Committee on Immunization Practices (ACIP) (De Serres, 2003; 
Kretsinger et al., 2006; see Appendix B; Table 3). These two evidence-based guidelines (see 
Appendix B; Table 3) approached the issue from a public health perspective and reached the 
same conclusions, where adults aged 19-64 years should receive a single dose of dTap to 
replace the Td vaccine (Kretsinger et al., 2006 & De Serres, 2003). 
The NACI guidelines state that "for adults who have not previously received a dose 
of acellular vaccine, it is recommended that a single diphtheria-tetanus (Td) booster dose be 
replaced by the combined diphtheria-tetanus-acellular pertussis (dTap) vaccine" (De Serres, 
2003, p.6). This evidence-based guideline is contained in a Canada Communicable Disease 
Report (De Serres, 2003) sponsored by the NACI, which is a rigorous accrediting body that 
ensures that "all material is correct as stated, methodology is appropriate conclusions are 
valid and defensible, [and] all parts of an article are consistent with all other parts" (NACI, 
2008). The level of evidence is rated 'Al', the highest rating, where NACI concluded that 
there is "good evidence to recommend immunization", which is supported by randomized 
controlled trials (De Serres, 2003; Public Health Agency of Canada, 2009). The NACI 
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guideline's credibility is entirely based on that of the publishing body, given that only the 
findings were published and that the criteria and methodology were not reported. This is 
"common with guidelines, forcing the user to accept the findings on faith or on the 
authority of the publishing body" (University of Washington, 2001). The many stakeholders 
involved do not cause a conflict of interest. The guideline is concise and does not contain 
extraneous information. Limitations of this guideline include the lack of recommendations 
for higher risk populations, including adults in contact with infants and health care workers. 
Immunization recommendations in the United States result from policies developed 
by the Advisory Committee on Immunization Practices (ACIP) of Centre for Disease Control 
(CDC}. Their recommendations agree with the NACI's advice in that they suggest that 
"adults aged 19-64 years should receive a single dose of dTap to replace tetanus and 
diphtheria toxoids vaccine (Td) for booster immunization against tetanus, diphtheria, and 
pertussis if they received their last dose of Td ~ 10 years earlier and they have not 
previously received dTap" (Kretsinger et al., 2006, p.1). Even though both NACI and ACIP are 
reliable government accrediting bodies, caution is warranted in that "clinical practice 
guidelines are often dependent on the politics of organizations involved in the treatment" 
(University of Washington, 2001). For example, if Adacel, the manufacturing company that 
produces dTap, was able to effectively lobby to influence either ACIP or NACI guidelines, 
then a clear conflict of interest would exist. 
The ACIP guideline further highlight adults who are at higher risk for susceptibility 
and transmission of pertussis, including those who are anticipating having close contact 
with infants less than 12 months and health care workers. ACIP recommends that adults 
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who are or anticipate being in contact with infants should receive a single dose of dTap to 
reduce the risk of transmission of pertussis. This could include parents, grandparents aged 
<65 years, child-care providers, or health-care personnel. The ACIP also recommend that 
women get vaccinated prior to pregnancy when possible. The vaccine is not approved for 
use in pregnancy. And for those who have not received dTap prior to pregnancy then it is 
recommended that they receive a dose in the immediate postpartum period (Kretsinger et 
al., 2006). 
The ACIP guideline also recommends that health care workers who work in hospitals 
or ambulatory care facilities and have direct patient care should receive a receive a single 
dose of dTap if they have not been previously vaccinated with acellular pertussis. The ACIP 
guideline indicate that an interval as short as two years from the previous Td immunization 
is recommended, however shorter intervals may be delivered (Kretsinger et al., 2006). 
Factors Affecting Low Pertussis Adult Vaccination Rates 
The systematic Review of Evidence Regarding Interventions to Improve Vaccination 
Coverage in Children, Adolescents, and Adults (Briss et al., 2000) examined the 
effectiveness, applicability, economic impact, and barriers of population-based 
interventions intended to improve vaccination coverage (see Appendix B; Table 1). One 
hundred and eighty-three qualifying studies were included and grouped according to 
validity. Nineteen of these studies provided strong evidence to recommend the reduction of 
out-of-pocket costs to increase effectiveness of immunization rates (Briss et al., 2000}. As 
mentioned above, the dTap vaccine for adults is not financially supported by the BC health 
care system. However, the vaccine is available at a $40.00 cost to the individual. 
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By way of example, the government of North West Territories (NWT) was the first to 
introduce NACI's recommended dTap for adults in into their immunization schedule free of 
charge (Northwest Territories Health and Social Services, 2009). There are no studies on the 
impact of pertussis adult immunizations yet; however, Kandola, Lea, White, and Santos 
(2005) studied the rates of pertussis cases in the NWT on adolescents. During three four-
year periods: the whole cell vaccine era (1993 to 1996), the pre-adolescent dTap era (1997 
to 2000), and the post-adolescent dTap era (2001 to 2004), they found that "the number of 
cases decreased from 186 to 129 to 19 cases in the three chronological time periods (i.e. 
whole-cell vaccine era, preadolescent dTap era and post-adolescent dTap era, respectively), 
with most of the substantial reduction coming with the introduction of post-adolescent 
dTap" (Kandola et al., 2005, p. 271). 
An additional factor regarding adult pertussis vaccination is the strong influence of 
NPs and other health care professionals on a person's decision to receive a vaccination. This 
was demonstrated in a telephone survey conducted in BC involving 800 adults who were 25 
years of age and older where adult behaviors related to Td vaccinations and beliefs 
regarding pertussis were assessed (Skowronski et al., 2004). It was found that a baseline of 
59% of the respondents would be willing to receive pertussis immunization if it was free. 
This figure increased to 76% after information was provided about communicability and 
severity of pertussis illness, and safety, effectiveness and convenience of vaccine. 
Respondent's willingness rose again to 87% if the information was accompanied by a 
physician or nurse recommendation. Furthermore, 63% of adults were willing to pay the 
$40.00 fee for the vaccine if required to pay. The 2006 Canadian Adult National 
Immunization Coverage Survey (NICS) also found that "the evidence is clear that the 
recommendation of a medical professional is a compelling factor in getting a vaccination, 
and that there are missed opportunities for preventative vaccination recommendations" 
(Public Health Agency of Canada, 2006a, p. 48). Twenty-nine studies in Briss et al.'s (2000) 
systematic review found strong evidence of the effectiveness of provider-based 
intervention to counsel patients on vaccinations. The 2006 NICS found that health care 
professionals, particularly doctors (74%), nurses (79%) and potentially NPs have the 
opportunity to provide vaccination information during the course of their work. 
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A third factor contributing to low adult vaccination rates, according to the National 
Consensus Conference on pertussis in 2002, is that "pertussis in adults may be under-
reported and there may be a lack of understanding and, therefore, a lack of appropriate 
action by some general practitioners, who may not realize that pertussis in adults should be 
taken seriously" (Public Health Agency of Canada, 2006a). If there is an increase in the 
understanding of issues and history of pertussis vaccinations in KB by NPs, General 
Practitioners (GPs), and public health RNs, then more recommendations would be given to 
the KB adult population resulting in increased adult pertussis vaccinations and a 
corresponding overall lower incidence of pertussis in the population. 
Strategies to Improve Vaccine Uptake in Adults 
The evidence provided by Briss et al.'s (2000) systematic review regarding 
recommendations to improve vaccination uptake in adults, which is supported by the 
Canadian Immunization Guide (Public Health Agency of Canada, 2006b), is grouped into the 
following three categories: (1) increasing community demand for vaccination, {2) provider-
based interventions and (3) enhancing access to vaccination services. Only the 
recommendations related to the research question, and more specifically, adults and 
potential programs related to adults (not including school programs), will be discussed. 
Community Demand for vaccination. 
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The evidence grouped into the first category, increasing community demand for 
vaccination, found strong recommendation for client reminder/recall systems (telephone 
calls, letters, postcards, etc. delivered to target populations), as well as multi-component 
interventions that "provide knowledge to target populations, and sometimes to vaccination 
providers, and use at least one other activity to improve vaccination coverage" (Task Force 
on Community Preventive Services, 2000, p.93). 'Other activities' include (from most 
common to least common among the qualifying studies) client reminders, provider 
education, expanded hours or access, provider reminders, reducing out-of-pocket costs, and 
client-held vaccination records. These strategies increase community demand for a vaccine, 
which is particularly effective if there is a lack of knowledge among people regarding the 
need for a vaccination. 
Provider-based interventions. 
Briss et al.'s (2000) second recommendation category, provider-based interventions, 
strongly recommended provider reminder/recall, assessment and feedback for vaccination 
providers as well as standing orders. Provider reminder/recall informs those who administer 
vaccinations that individual patients are due (reminder) or overdue (recall) for specific 
vaccinations. Techniques of how this was delivered include reminders in client charts, by 
computer, or by mail. Vaccination assessment and feedback involves evaluating the 
performance of the provider who delivers the vaccine and then giving this provider the 
feedback. Standing orders enable non-prescriber health care workers to administer the 
vaccine through a protocol, which do not involve the prescriber at the time of the client-
personnel interaction. 
Enhancing access to vaccination services 
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The final group, enhancing access to vaccination services, highly recommends 
reducing out-of-pocket costs by providing free vaccinations and administration. Multiple 
reputable studies found this was effective when applied alone or as part of a multi-
component intervention. Other recommendations (if used in combination with other 
interventions) to improve access included expanding access to medical or public health 
clinical settings. Suggestions included reducing the distance from the clinic to the 
population, increasing or accommodating the clinic's hours to the needs of the population, 
providing vaccinations in clinical settings not previously provided (inpatient units, 
emergency departments), and reducing administrative barriers, such as developing a "drop-
in" clinic or an "express lane" vaccination service {Briss et al., 2000, Public Health Agency of 
Canada, 200Gb). 
Cost-benefit and Cost-effectiveness Analysis of Adult dTap Vaccination 
In order to effectively create and implement a plan for increasing adult dTap 
immunizations information regarding the cost-effectiveness of immunizing adults against 
pertussis must be available. This knowledge is vital to the process of gaining government 
financial support. Therefore, through the use of evidence based practice, the following 
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section analyzes the question: would administration of adult dTap as compared to Td be a 
cost effective utilization of the Canadian health care dollar for the people in the KB region? 
Meta-analysis. 
The first three meta-analysis' examined (see Appendix B; Table 2) and specifically 
addressed the cost effectiveness issue and presented disparate results. Purdy et al.'s {2004) 
evaluation indicated that adult pertussis vaccination would result in cost-savings. However, 
Lee et al.'s (2005) analysis indicated that adult pertussis vaccination would not be cost-
effective. These studies had two major differences. Firstly, Purdy et al.'s evaluation used a 
time horizon often years; where Lee et al.'s {2005) strategy used decennial boosters over 
the lifetime of adults. Secondly, the incidence estimates used in these two studies differed 
greatly. Purdy et al's conclusion was based on an incidence that ranged 159 to 548 per 
100,000 population for adults. In comparison, Lee et al. (2005) used a more conservative 
estimate of 11 per 100,000 adult population. Neither study "made adjustments for a wider 
spectrum of disease severity with increased incidence" (Lee et al., p. 187, 2007). 
To address these inconsistencies, Lee et al. {2007) re-examined the cost-
effectiveness of dTap in adults using additional updated estimates on disease incidence, 
which is summarized in Cortese et al.'s {2007) article on morbidity and incidence of 
pertussis in US adults. Lee eta I.'s (2007) study found that "routine vaccination of adults 
aged 20 to 64 with combined tetanus toxoid, reduced diphtheria toxoid, and acellular 
pertussis is cost effective if pertussis incidence in this age group is greater than 120 per 
100,000 population" (p.186). This analysis of cost effectiveness incorporates direct medical, 
non-medical costs and productivity costs (time missed from work). These costs include 
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laboratory tests, ambulatory visits, hospitalization, chest radiography, antibiotics, vaccine 
acquisition, and administration, as well as transportation, childcare and over-the-counter 
medications. Vaccine adverse events were also considered in the analysis. Furthermore, 
QALYs were used in the study as a valid and commonly used method to measure the benefit 
of vaccination programs. QALY is a measure of disease burden, which includes both the 
quality and the quantity of life lived (National Institute of Health and Clinical Excellence, 
2009}. 
Lee et al. (2007) use a meta-analysis, where the results from numerous resources 
create a sample size equivalent to the US adult population (see Appendix B; Table 2). This 
sample size is the largest of the four meta-analyses, which reflects "greater power to 
determine the true magnitude of an effect" (Melnyk & Fineout-Overholt, p. 115, 2005). Lee 
et al.'s use ofthe most up-to-date published and unpublished sources, including Cortese et 
al.'s study (2007, see Appendix B; Table 2-4th article), minimizes bias and increases validity. 
Lee et al.'s meta analysis demonstrates applicability to cost-benefit analysis by providing 
clear parameters of when dTap in adults is cost-effective and when it is not. The few 
discrepancies that weaken the review include that a systematic search for the data was not 
reported and that methods of how the Markov model synthesized evidence was not 
indicated. 
Four out of the five authors from the second meta-analysis also published the first 
study (Lee et al., 2005; Lee et al., 2007; see Appendix B; Table 2}. However, the conclusions 
drawn from the second study are in opposition to the first . This presents a strong argument 
indicating validity of both articles considering the same authors were willing to conclude 
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different positions on the cost-effectiveness of dTap in adults. Lee et al. (2005) acknowledge 
that their results were limited due to their use of passive incidence rates, lack of 
information on pertussis transmission and duration of the effectiveness of the vaccine. 
Evidence-Based Guidelines on cost effectiveness 
The only evidence-based guideline found in the literature review that addresses cost 
effectiveness is supported by the ACIP (Kretsinger et al., 2006). ACIP reviews the economic 
considerations for adult dTap use and supports Lee et al.'s (2007) conclusion that acellular 
pertussis vaccination of adults aged 20 to 64 is cost effective if pertussis incidence in this 
age group is greater than 120 per 100,000 population .. In order to apply Lee et al.'s (2007) 
results to the issue of cost effectiveness of adult dTap immunization, one must know the 
rate of pertussis aged 19-64 years in the KB region. 
The British Columbia Annual Summary of Reportable Diseases (BCCDC, 2007) 
reported peak incidence of pertussis in 2000, 2003 and 2006, which is reflective of its three 
to five years cyclical pattern. This corresponded with the respective rate of pertussis in the 
KB region of 119.6, 55.4 and 134.4 per 100,000 population of all ages. Therefore, proven 
cost effectiveness is limited to the years that these peaks occur. Although, due to the 
complications in diagnosis causing significant underestimates of incidence, cost-
effectiveness is likely to be greater than is currently measurable. 
Problems in Determining Incidence of Pertussis 
Pertussis is difficult to track due to: 1) the fastidious biology of the organism, 
Bortetella pertussis, and 2) limitations of diagnostic laboratory tests. Compared to short 
incubation periods of most other respiratory bacterial pathogens, pertussis has a prolonged 
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incubation period from one to three weeks (McNeil & Ohl, 2009; Edwards, 2001). Despite 
these long incubation and symptomatic periods, pertussis frequently cannot be cultured. 
Edwards {2001} emphasizes that "how the organism [pertussis] can produce such prolonged 
symptoms when it cannot be cultured remains an unanswered question, which highlights 
our poor understanding of its pathogenesis" (p.1698}. 
Common laboratory techniques used for pertussis case detection include bacterial 
culture, nucleic acid amplification by polymerase chain reaction (PCR), and serological 
testing. Sensitivity, specificity and interpretation of these tests are complicated by "the 
stage of the disease, antimicrobial administration, previous vaccination, the quality of 
technique used to collect the specimen, transport conditions to the testing laboratory, 
experience of the laboratory, contamination of the sample, and use of nonstandardized 
tests" (Kretsinger et al., 2006, p. 5) BCCDC utilizes bacterial culture and PCR assay as 
laboratory confirmation of pertussis cases (Provincial Health Services Authority, 2009}. This 
is the method that NPs utilize to test for pertussis in primary care. 
Traditional"gold standard" method for diagnosis of the disease is culture of B. 
pertussis from nasophayngeal secretions. This method of diagnostic testing has a specificity 
of 100%, but is limited by its sensitivity of 15-60% (McNeil & Ohl, 2009}. Culture sensitivity 
declines rapidly after cough onset. This was demonstrated in a study of 261 pertussis case 
patients where the culture sensitivity fell progressively from 55% (within the first week after 
cough onset) to 42%, 25%, and 10% for specimens obtained in the second, third and forth 
week respectively (Sotir et al., 2007). These limitations have challenged the role of culture 
and have been replaced by other diagnostic methods. The KB region utilizes PCR assays to 
confirm pertussis cases. 
PCR based tests have many advantages over bacterial culture testing. These include 
"faster results (one to two days versus three to seven days), higher yield in the setting of 
vaccination and antimicrobial therapy, [and] higher sensitivity, particularly if performed 
more than one week after symptom onset" (McNeil & Ohl, 2009). Even amongst these 
advantages, PCR's sensitivity diminishes rapidly after onset of cough from 81% within the 
first two weeks to 65% on the third week. Both bacterial culture and PCR's high specificity 
provides evidence of pertussis infection; however, their low sensitivity implies that a 
negative result does not rule out pertussis. Consequently, "insensitive culture and PCR 
methods for diagnosis of pertussis lead to lower disease estimates when compared with 
serologic methods," (Edwards, 2001, p. 1698}. 
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Insensitive bacterial culture and PCR methods of pertussis diagnosis were further 
exemplified in a comprehensive Canadian study that attempted to determine the rates of 
pertussis in adolescents and adults (Senzilet, et al, 2001}. Pertussis was tested in 442 
adolescents and adults with a cough illness greater than one week in duration. The results 
demonstrated that only 2.3% of the subjects had confirmed diagnosis of pertussis by culture 
or PCR. In contrast, nearly 20% of the adolescents and adults had single antibody titers that 
were >3 standard deviations than the geometric mean titer for control subjects (Senzilet, et 
al, 2001). 
In the past, serologic methods of diagnosing pertussis have been used in 
epidemiologic investigations or vaccine trials (Byrd & Ohl, 2009}. Massachusetts state 
laboratory and selected countries of the European Union have adopted this serologic 
method. This method for pertussis diagnosis involves the detection of serum antibodies, 
which are measured by enzyme-linked immunosorbent assay (ELISA) (Byrd & Oht 2009). 
Serology is not recognized or utilized by the BCCDC to diagnose pertussis. 
Discussion 
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There is sufficient credible evidence from Canadian and American national 
guidelines to conclude that the consensual recommendation for adults aged 19-64 who 
have not received acellular pertussis vaccine is that they should receive a single dose of 
dTap to replace the Td vaccine (Deserres, 2003; Kretsinger et al., 2006, Public Health Agency 
of Canada, 2006b). Targeted populations for updated pertussis immunizations include 
adults in close contact with infants <12 months (most at risk for pertussis related death), 
which includes parents, grandparents (<65 yearsL child care workers, any woman who 
might become pregnant and post partum women, as well as health care workers (Kretsinger 
et al., 2006). 
Factors affecting low pertussis rates in adults were found to be related to lack of 
financial support from the BC government to pay for the vaccine, missed opportunities by 
the practitioner to vaccinate and finally, lack of understanding and appropriate action by 
some practitioners, which leads to under diagnosis and reporting (Public Health Agency of 
Canada, 2006b; Briss et al., 2000; Skowronski et al., 2004, Public Health Care Agency of 
Canada, 2006a). 
The literature substantially supports many strategies that NPs could use in practice 
to improve uptake of vaccinations in adults, including increasing community demand for 
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vaccination (client reminder/recall systems via telephone, postcards, etc), provider-based 
interventions (client reminders in patients charts, assessment and feedback for vaccination 
providers, as well as standing orders), and enhancing access to vaccination services 
(reduction of out-of-pocket costs) (Public Health Agency of Canada, 2006b; Briss et al., 2000; 
Public Health Care Agency of Canada, 2006a; Task Force on Community Preventive Services, 
2000). 
The most current meta-analysis, as well as the ACIP found adult dTap vaccination 
cost-effective if the incidence of pertussis is greater than 120 per 100,000 adult population 
(Lee et al, 2007; Kretsinger, 2006). This accounts for medical and non-medical costs, as well 
as productivity costs. Cost effectiveness is difficult to determine due to the fastidiousness of 
the organism, its cyclical pattern, passive reporting, as well as under diagnosis and 
reporting. The BCCDC reported cyclical peak incidence of pertussis in 2000, 2003 and 2006, 
which corresponded with the respective rate in the KB region of 119.6, 55.4 and 134.4 per 
100,000 population (for all ages). Therefore proven cost-effectiveness is limited to the years 
that these peaks occur. Although, due to the complications in diagnosis causing significant 
underestimates of incidence, cost-effectiveness is likely to be greater than is currently 
measurable. 
NPs and other providers need to know the most current recommendations and 
implementation strategies regarding adult pertussis in order to increase rates of 
immunizations. Chapter 3 will discuss the implications for nurse practitioner practice, which 




Implications for Nurse Practitioner Practice 
In review of the literature on adult pertussis immunizations, there are four main 
conclusions that should guide clinical practice. First, the NP needs to improve diagnosis and 
subsequent surveillance of pertussis in adults. Second, NPs must recommend adults dTap to 
their patients, particularly those who are high risk and in close contact with infants. Thirdly, 
NPs must implement vaccination strategies into their own practice, as well as the broader 
community. And finally, NPs need to lobby the BC government to reduce out-of-pocket 
expenses by requesting funding for pertussis vaccinations for adults. 
Improve Pertussis Diagnosis 
An increased awareness by NPs ofthe prevalence and under-diagnosis of pertussis in 
adults can improve patient assessment and subsequent surveillance of the disease. This is 
not an easy task considering the catarrhal (initial) phase is clinically indistinguishable from a 
viral upper respiratory tract infection (McNeil & Ohl, 2009). In children, it is not until the 
paroxysmal phase at one to ten weeks of the disease process, where the distinguishable 
bursts of numerous rapid coughs (paroxysms) followed by a high-pitched whoop is 
recognizable. In adults, the disease presents differently, where it is frequently characterized 
only by a prolonged, persistent cough that is often misdiagnosed as acute bronchitis. Other 
symptoms can include coryza (head cold), sore throat, malaise and a low-grade fever. The 
average duration of cough is 36 to 48 days (McNeil & Ohl, 2009). It is crucial that NPs have a 
high degree of suspicion for pertussis to make a prompt diagnosis of pertussis when 
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confronted with a patient, both children and adults, with the common cough . This early 
diagnosis is essential for the prevention and control of pertussis to others in the community. 
Pertussis Prevention in NP Practice 
The literature review clearly indicates that NPs should recommend acellular 
pertussis vaccine for adults aged 19-64 who have not received dTap; they should receive a 
single dose of dTap to replace the Td vaccine (Deserres, 2003; Kretsinger et al., 2006, Public 
Health Agency of Canada, 200Gb). This is heavily supported by credible Canadian and 
American guidelines despite its omission from the BCCDC guidelines. A subsequent fee of 
forty dollars for the vaccination is at a cost to the individual. NPs need to pay close attention 
to higher risk groups and target adult populations in close contact with infants (<12 
months), which includes parents, grandparents (<65 years), child care workers, any woman 
who might become pregnant and post partum women, as well as health care workers 
(Kretsinger et al., 2006). In order to decrease the incidence of missed opportunities to 
vaccinate, strategies for NPs and other providers have been well researched with specific 
recommendations. 
Vaccination Strategies and Implications for Clinical Practice 
Primary care NPs are in a un ique role in that they can implement client specific 
strategies, as well as coordinating broader population health promotion programs to 
improve adult pertussis vaccine uptake. These implementation strategies include 
coordination of a task force for the development and distribution of educational materials 
(patient education), development of systems for inclusion of immunization status in routine 
visits (provider-based interventions), coordinating programs to increase community 
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demand as well as collaborating with other health professionals to disseminate knowledge 
on adult pertussis vaccine. 
NPs need to counsel all adults aged 19-64 years, especially target populations who 
are most at risk for pertussis and the transmission of disease to infants, about their 
immunization status and the evidence that supports pertussis vaccination. These population 
includes parents, grandparents <65 years of age, child care workers, and any woman who 
might become pregnant and postpartum women. Health care workers are also at high risk 
for the acquisition and transmission of pertussis and should be targeted for immunization. 
It is well documented that primary care practitioners often miss opportunities to 
vaccinate in outpatient clinics and offices (Public Health Agency of Canada, 2006a; Briss et 
al., 2000; Kretsinger et al., 2006). NPs must develop systems for inclusion of immunization 
status in routine visits whereby a task force regularly reviews adult's immunization status 
and have client reminders in their paper charts or electronic medical records. This is 
particularly relevant for new vaccines such as dTap since the patient is less likely to be 
aware of or request the vaccination. The assessment of a new patient's medical history or 
annual physical is another opportunity where patients should be asked about their 
immunization status; this is not only suggested for children, but adults as well. The system 
should also include routine audits of patient's immunization status by the task force and 
subsequent mailing (or emailing) client reminders which will enhance vaccination uptake. 
And finally, implementing age-based strategies, such as reviewing adult immunization 
records that coincide with decennial birthdays (i.e.: 20, 30, 40, 50 years etc.). These 
provider-based interventions have been proven to be effective ways to increase vaccination 
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rates particularly when they are implemented in combination with other interventions, such 
as increasing community demand. (Briss et al., 2000; Task Force on Community Preventive 
Services, 2000). 
Methods where NPs can increase community demand for adult dTap can occur 
through the coordination of a task force for the development and dissemination of these 
educational materials to other health professionals. This could include creating pamphlets 
and posters, which would be distributed by administration assistants at NP clinics. These 
would provide information on communicability and severity of pertussis illness and safety, 
efficacy and convenience of vaccine. Once provider-based interventions are in place, an 
assessment of the effectiveness of these strategies must occur. This could contribute as part 
of CRNBC's personal practice review requirements for continuing competence and licensing 
renewal. 
The literature indicates that pertussis immunizations in adults are the least 
understood (Public Health Agency of Canada, 2006a). Education to colleagues is another 
proactive approach where NPs could be instrumental in increasing the awareness of the 
need for adult pertussis immunization. The author could present the findings of this paper 
to the British Columbia Association Nurse Practitioner (BCNPA) conference, which is 
particularly relevant considering the theme for the up-coming conference of health 
promotion. NPs could also provide presentations at local'rounds' and educational in-
services in community hospitals to nurses and physicians, as well as directly to the 
communicable disease representative for the KB area. Further, NPs could present 
workshops to local public health RNs. There would be an opportunity during these 
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presentations to have a question and answer period where adult pertussis immunizations 
would be open for discussion. Pamphlets could be shared so that other primary care 
practitioners could also have the information available to their patients. Gaining health care 
provider awareness and support would provide momentum to increase advocacy and 
collectively help mobilize political action to protect against pertussis. 
Lobbying the BC government 
NPs are becoming recognized as crucial members ofthe health care team in their 
community and can provide leadership in health promotion. As NPs it is incumbent upon us 
to exercise our voices politically and challenge the status quo through best practice 
initiatives concerning immunizations such that we promote the well-being of individuals, 
families and communities (College of Registered Nurses of British Columbia, 2006). In 
attempting to create policy change, EBP is particularly powerful when confronting those in 
authority because it involves "conscientious, explicit and judicious use of current best 
evidence in making decisions" (Sacket, Rosenburg, Grey, J, Haynes, & Richardson, 1996). 
Even though proven cost effectiveness is limited to the years of peak incidence, 
evidence stemming from the literature review indicates that one dose of adult pertussis 
immunization is strongly recommended to adults aged 19-64 years of age (Deserres, 2003; 
Kretsinger et al., 2006; Public Health Agency of Canada, 2006b). The use of this evidence can 
be used by NPs and their political influence. This can be exercised through direct lobbying of 
local political representatives at the regional district and provincial levels, which will help to 
increase pressure for funding and for policy change by the IHA and BCCDC. Submitting 
articles to local newspapers, conducting local radio interviews, and organizing information 
booths at malls, community markets and fairs are several other options to articulate the 
political NP voice. 
Recommendations 
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In response to the research question of how to most effectively create and 
implement change to increase adult dTap immunization and consequently decrease 
morbidity and mortality in vulnerable populations the following are key recommendations 
for NPs to implement into their practice: 
~ Evidence indicates that pertussis in adults is poorly understood and under-diagnosed 
by primary health care providers (Kretsinger et al., 2006; Public Health Agency of 
Canada, 2006a; De Serres, 2003}. NPs need to have a higher degree of suspicion for 
pertussis in adults when presented with a common cough. 
~ NPs need to educate patients and other health care professionals about the 
Canadian and American recommendations that all adults aged 19-64 years of age 
should receive dTap in replacement of the Td vaccine who have not received one 
dose of acellular pertussis despite the forty dollar cost to the individual. (De Serres, 
2003, Kretsinger et al., 2006). 
~ Identify and focus on target populations who are at greater risk of acquisition and 
transmission of pertussis include adults who are in contact with children, which 
includes parents, grandparents (<65 yearsL child care workers, any woman who 
might become pregnant and post partum women, and health care workers 
(Kretsinger et al., 2006; Public Health Agency of Canada, 2006a). 
31 
)> Strategies to increase immunization in adults are most effective when used in 
combination. Specifically, enhanced access to vaccination services (expanded access 
in health-care settings or reduced client out-of-pocket costs) with either a provider-
or system-based intervention (standing orders, provider reminder systems, or 
provider assessment and feedback) or an intervention to increase client or 
community demand for vaccination (client reminders or client education) (Briss et 
al., 2000; Task Force on Community Preventive Services, 2000). 
)> Evidence indicates that reducing out-of-pocket costs independent of other 
interventions improves vaccination coverage in adults (Briss et al., 2000; Task Force 
on Community Preventive Services, 2000; Public Health Agency of Canada, 200Gb). 
NPs need be lobby their local political representatives to change BCCDC policy to 
extend financial support to include the pertussis vaccination for adults. 
Conclusion 
A publicly funded and successful administration of pertussis immunization for adults 
could have diminished the degree of the KB pertussis outbreaks in the past 10 years which 
exceed the BC norms. While adolescents and younger adults account for the majority of 
recently reported cases of pertussis, often the first person in the household with the 
infection is an older adult who has been immunized during childhood against the disease, 
but has no current protection (Public Health Agency of Canada, 2005; Kretsinger et al., 
2006, De Serres, 2003). Ease of communication combined with the duration of pertussis 
make primary prevention of the disease via immunization critically important. As well, 
issues around diagnosis and diagnostic testing continue to be problematic. This is where an 
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NP initiated change to reduce the burden of pertussis in the KB population can have a major 
effect. 
The focus of this paper examined the unique role of the NP in primary health care by 
increasing the immunization rates of adult dTap and subsequently decreasing pertussis 
morbidity in the KB population. This has been extensively discussed from communicability, 
educational, immunization strategies, advocacy, financial and political action perspectives. 
The contextual background of changes to the pertussis vaccine provides a foundation of 
knowledge of how the problem has in-part evolved over the past 70 years since its first 
introduction. The corresponding fluctuations in morbidity that have accompanied these 
changes were also examined. 
Through evidence based research, the literature review revealed that pertussis in 
adults is poorly understood and under-diagnosed in primary care practitioners. American 
and Canadian national guidelines were found to recommend that all adults aged 19-64 who 
have not received dTap should receive a single dose of dTap to replace the Td vaccine. 
Target populations who are at greater risk of acquisition and transmission of pertussis were 
identified. 
It was found that NPs can improve vaccination rates in adults by educating patients 
and colleagues about these recommendations. Furthermore, the following factors, 
preferably in combination, improve rates: 
• enhanced access to vaccination services -i.e. reducing out-of-pocket costs or 
expanded access in health care settings; 
• provider- or system-based intervention -i.e. standing orders, provider reminder 
systems, or provider assessment and feedback; 
• intervention to increase client or community demand for vaccination -i.e. client 
reminders or client education. 
As mentioned, the above strategies are most effective when used in combination (Briss et 
al., 2000; Task Force on Community Preventive Services, 2000}. 
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Society not only expects health practitioners to promote newly approved 
interventions, such as vaccines that help maintain health and prevent disease, but also 
desires that the general population receive continuing and updated protection through 
appropriate immunization. NPs must extend their efforts beyond the process of diagnosing 
and treating to include challenging entrenched social or economic policies that can 
adversely affect biomedical issues (Browne & Tarlier, 2008). NPs are educated to view 
health from micro to macro levels, alongside a holistic focus. High pertussis rates in the KB 
region provide an opportunity for NPs to be effective agents of change in their clinical 
practice and broader political voices to improve the adult immunization rates of pertussis in 
the KB region. 
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Appendix A: Pertussis Rates in BC 
Pe r t us-sis Rates by HS DA, 2006 
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